TipRanks
Quoin Pharmaceuticals (DE:2EB0)
FRANKFURT:2EB0
Germany Market
2EB0
Quoin Pharmaceuticals
RESEARCH TOOLSreports

Quoin Pharmaceuticals (2EB0) Stock News & Sentiment

0 Followers
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
Premium
Company Announcements
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
8d ago
8K
QNRX
Quoin Reports Positive Interim QRX003 Netherton Data
Premium
Company Announcements
Quoin Reports Positive Interim QRX003 Netherton Data
21d ago
8K
QNRX
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
Premium
Company Announcements
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
29d ago
8K
QNRX
QNRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
QNRX Upcoming Earnings Report: What to Expect?
1M ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
Premium
Ratings
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
3M ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
Premium
Company Announcements
Quoin Advances QYLEKI Toward First Netherton Therapy
3M ago
8K
QNRX
Quoin Wins Japan Orphan Drug Status for QRX003
Premium
Company Announcements
Quoin Wins Japan Orphan Drug Status for QRX003
4M ago
8K
QNRX
More DE:2EB0 News >

2EB0 News on the Web

Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
TipRanks News
Neutral
Quoin Reports Positive Interim QRX003 Netherton Data
TipRanks News
Neutral
Quoin Pharmaceuticals (QNRX) Raises $50M, Shares Surge 38% Premarket Amid Growth Prospects
GuruFocus News
Bullish
Quoin Pharmaceuticals (QNRX) Surges 38.5% Premarket Amid Growth Speculation Despite Unprofitability
GuruFocus News
Bullish
Maxim Group Remains a Buy on Quoin Pharmaceuticals (QNRX)
TipRanks News
Bullish
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
TipRanks News
Bullish
Quoin Advances QYLEKI Toward First Netherton Therapy
TipRanks News
Neutral
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2EB0’s Media Buzz Sentiment?
Currently, no data Available
What is DE:2EB0’s weekly average amount of articles?
In an average week, 2.75 articles about DE:2EB0 are published.
    What is DE:2EB0’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    SLDBSolid Biosciences
    CRLCharles River Labs
    ASNDAscendis Pharma
    CRBPCorbus Pharmaceuticals
    RVMDRevolution Medicines
    Showing the stocks with the most bullish news sentiment over the past week